Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven®) in obstetrical haemorrhagic shock

被引：0
|
作者：
S Sobieszczyk
GH Breborowicz
B Kubiaczyk
T Opala
机构：
[1] University of Medical Sciences,Laboratory of Cardiovascular and Haemostasis Disorders, Department of Mother and Child Health
[2] University of Medical Sciences,Department of Perinatology and Gynaecology
[3] University of Medical Sciences,Department of Mother and Child Health
来源：
Critical Care | / 7卷 / Suppl 2期
关键词：
Emergency Medicine; Conventional Method; Prothrombin; Small Dose; Hemorrhagic Shock;
D O I：
10.1186/cc1994
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Recombinant activated factor VII (rFVIIa): From concept to clinical utility - Preface
    Mammen, EF
    Michiels, JJ
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04): : 361 - 362
  • [42] Hemostasis in severe postpartum hemorrhage - The effect of recombinant activated factor VII (RFVIIA)
    Segal, S
    Shemesh, IY
    Yoffe, B
    Laufer, N
    Mankuta, D
    Mazor, M
    Zohar, S
    Shiff, E
    Ben-Tal, O
    Pauzner, D
    Martinowitz, U
    THROMBOSIS RESEARCH, 2005, 115 : 141 - 141
  • [43] Efficacy of low-dose recombinant activated factor VII (rFVIIa) in massively transfused trauma patients with coagulopathy
    Quillen, K
    Hirsch, E
    Bauza, G
    BLOOD, 2005, 106 (11) : 279A - 279A
  • [44] Recombinant activated factor VII (NovoSeven®) treatment of platelet-related bleeding disorders
    Poon, MC
    d'Oiron, R
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S55 - S68
  • [45] Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven®) in children vs adults with haemophilia A
    Villar, A
    Aronis, S
    Morfini, M
    Santagostino, E
    Auerswald, G
    Thomsen, HF
    Erhardtsen, E
    Giangrande, PLF
    HAEMOPHILIA, 2004, 10 (04) : 352 - 359
  • [46] Recombinant activated factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
    Baudo, F
    Gaidano, G
    Carloni, MT
    Coppola, A
    Fariciotti, A
    Iorio, A
    Marietta, M
    Marongiu, F
    Mazzucconi, MG
    Miraglia, E
    Schiavoni, M
    Schinco, PC
    BLOOD, 2002, 100 (11) : 100B - 100B
  • [47] Efficacy and safety of recombinant activated factor VII in the management of hemorrhagic shock due to trauma
    Hauser, C. J.
    Boffard, K. D.
    Dutton, R. P.
    GR, Bernard
    Croce, M. A.
    Holcomb, J. B.
    Leppaniemi, A. K.
    Parr, M. J. A.
    Vincent, J. L.
    Tortella, B. J.
    Dimsits, J.
    Bouillon, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 290 - 291
  • [48] Recombinant factor VII (activated) for haemorrhagic complications of severe sepsis treated with recombinant protein C (activated)
    Michalska-Krzanowska, Grazyna
    Czuprynska, Maria
    ACTA HAEMATOLOGICA, 2006, 116 (02) : 126 - 130
  • [49] Successful treatment of cyclophasphomide-induced intractable haemorrhagic cystitis with NovoSeven (recombinant activated factor VII) after allogeneic bone marrow transplantation
    Zakerinia, M
    Khojaste, HN
    Ramzi, M
    Haghshenash, M
    Karimi, M
    Ahmad, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S120 - S120
  • [50] Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding:: a report by the Israeli Multidisciplinary rFVIIa task
    Ariëns, RAS
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 649 - 650
12345